semaglutide and immune system Use of linked to doubled risk of neovascular macular degeneration Anti-inflammatory benefits of semaglutide: State

In this mini-review, we prioritized the reporting of the most relevant articles regarding the role of GLP-1 RAs on coronary atherosclerosis, vasospasm, microcirculation, and subsequent coronary events

90% of participants Achieved A1c of less than 7% Lost up to 10.5kg (23.10lbs) Improvements seen in 40 weeks Side effects: diarrhea and nausea The dose used in these trials ranged from 5 to 15 mg

& Hinton, G

Abstract The global incidence of steatotic liver disease (SLD), driven by metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-associated liver disease (ALD), and the synergistic metabolic dysfunction and alcohol-associated liver disease (MetALD), is fueling a rapid rise in hepatocellular carcinoma (HCC)